ReOpen was the first ever large placebo-controlled clinical trial program to demonstrate statistically significant reduction of symptoms in chronic sinusitis…
Information concerning the total number of voting rights and shares, provided pursuant to article L. 233-8 II of the Code…
The certification has the potential to open access to Islamic markets globally, expanding potential markets for Scilex’s innovative FDA approved…
Gain Therapeutics’ Former CEO and current Board Member Eric Richman to participate in fireside chat hosted by Public Ventures President…
Exploring the Relationship Between Glial Cells and Electromagnetic Waves David Dardashti and Quantum Electrodynamic Ibogaine By David Dardashti supports quantum…
Ibogaine By David Dardashti applies the principles of Quantum Electrodynamics and Chaos Theory to optimize the ibogaine experienceMIAMI, March 15,…
PLEASANTON, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Healthcare Triangle, Inc. (Nasdaq: HCTI) (“Healthcare Triangle,” “HCTI” or the “Company”), a…
NEW YORK, March 15, 2024 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a…
SAN DIEGO, March 15, 2024 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the…
PALO ALTO, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Scilex Holding Company (Nasdaq: SCLX, “Scilex” or “Company”), an innovative revenue…